Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab

Authors

Keywords

Journal

Volume 74, Issue 8, Pages 961

Publisher

American Medical Association (AMA)

Online

2017-06-13

DOI

10.1001/jamaneurol.2017.0676

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now